Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liebman

Showing results (161-170 of 216) with videos related to

Pageof 22
Sort By:
Thrombosis Research|October 27, 2009
Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismDavid A Manly, Jianguo Wang, Sam L Glover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancyJeffrey I Zwicker, Howard A Liebman, Donna Neuberg, et al.
Radiology|August 1, 1991
Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanningV W Lee, J D Fuller, M J O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevanceCasey L O'Connell, William D Boswell, Vinay Duddalwar, et al.
American Journal of Clinical Pathology|November 1, 1992
Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinaseH A Liebman, M K Carfagno, I C Weitz, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2012
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancerM N Levine, C Gu, H A Liebman, et al.
British Journal of Haematology|July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I studyHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Haematologica|August 13, 2016
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopeniaHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Thrombosis Research|May 1, 2012
Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formationIlene C Weitz, Pedram Razavi, Leanne Rochanda, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
AIDS in intravenous drug users: issues related to enrollment in clinical trialsD E Craven, H A Liebman, J Fuller, et al.
Pageof 22

Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
Thrombosis Research|October 27, 2009
Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismDavid A Manly, Jianguo Wang, Sam L Glover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancyJeffrey I Zwicker, Howard A Liebman, Donna Neuberg, et al.
Radiology|August 1, 1991
Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanningV W Lee, J D Fuller, M J O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevanceCasey L O'Connell, William D Boswell, Vinay Duddalwar, et al.
American Journal of Clinical Pathology|November 1, 1992
Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinaseH A Liebman, M K Carfagno, I C Weitz, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2012
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancerM N Levine, C Gu, H A Liebman, et al.
British Journal of Haematology|July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I studyHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Haematologica|August 13, 2016
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopeniaHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.
Thrombosis Research|May 1, 2012
Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formationIlene C Weitz, Pedram Razavi, Leanne Rochanda, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
AIDS in intravenous drug users: issues related to enrollment in clinical trialsD E Craven, H A Liebman, J Fuller, et al.
Pageof 22